Project Grant R01NS143180
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded UCLA a Project Grant totaling $551,250 on June 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The research focuses on understanding the molecular basis of synaptic specificity in the Drosophila melanogaster visual system. The project will investigate how neurons form precise synaptic connections through cell...
- This $660,000 federal Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research at the University of Southern California (USC) on how RNA editing regulates synaptic plasticity and behavioral adaptations in the fruit fly Drosophila melanogaster. The project aims to investigate how RNA editing of glutamate-gated chloride and voltage-gated calcium channels impacts neural circuit function, synaptic plasticity, and organismal behaviors....
- Federal Grant Award Summary The University of Colorado-Denver received a $180,249 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded on July 23, 2025, with a completion date of November 30, 2026. This award supports investigator-initiated research investigating the mechanisms and impact of amyloid-beta mediated disruption of synaptic...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $185,042 to The Regents of the University of Colorado (University of Colorado-Denver) on July 14, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project, titled "The Role of Subsynaptic Nanoscale Architecture in Inhibitory Synaptic Plasticity," will be conducted in Aurora, Colorado, and is scheduled for...
- This federal Project Grant award of $364,448.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) focuses on investigating the neural functions of glycoprotein sialylation. The research aims to reveal sialylation-mediated mechanisms of glia-neuron coupling, elucidate the role of sialylation in promoting neuronal viability and resistance to oxidative stress, and characterize...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $676,789 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program to the Buck Institute for Research on Aging. The grant supports research to investigate the in vivo impact of N6-methyladenosine (m6A), a common mRNA modification, on synaptic function and neurotransmitter release. The research aims to establish critical roles for the epitranscriptome in...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University a Project Grant totaling $443,736 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for the period July 1, 2025 through June 30, 2030. The award funds fundamental neuroscience research investigating neuropeptide modulation in circadian neural circuits, with the objective of understanding how intercellular...
- Federal Grant Award Summary Oregon Health & Science University received a $148,050 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective December 1, 2025, through May 31, 2028. This award supports investigator-initiated basic research to advance understanding of neuronal development and disease mechanisms relevant to neurodevelopmental...
- Federal Grant Award Summary Drexel University received a $241,764 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective May 1, 2025, with completion targeted for October 14, 2026. The research project investigates the mechanisms and functions of the transcription factor Broad as a terminal selector in the fruit fly (Drosophila...
- Federal Project Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $448,200 on September 30, 2025, under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) to support research conducted through the Research Foundation of the City University of New York at City College. The three-year project, extending through September 29, 2028, focuses on understanding the fundamental biological...
This Project Grant award of $496,279 was obligated on March 1, 2026, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). Colorado State University's Sponsored Programs Division will conduct fundamental research to elucidate the molecular mechanisms underlying cholinergic synaptic homeostasis—the ability of neurons to compensate for altered neural activity—through the completion date of November 30, 2030. This research employs Drosophila as a genetically tractable model system to validate cholinergic homeostatic synaptic plasticity (HSP) in intact neural circuitry and to investigate the specific roles of the ER protein NACHO, transcription factors NFAT and CREB, and downstream ion channel genes in regulating this process. The research deliverables will contribute scientific knowledge regarding cholinergic nervous system plasticity mechanisms, with findings expected to inform understanding of comparable processes in mammalian systems and potentially yield therapeutic applications for neurological conditions such as Alzheimer's disease. By characterizing highly conserved ion channel and cellular regulatory mechanisms in the fruit fly central nervous system, this investigation addresses a significant gap in synaptic plasticity research, which has historically focused on glutamatergic rather than cholinergic synapses, thereby advancing the NINDS mission to reduce the burden of neurological disease through fundamental neuroscience investigation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $496.3k | 2/27/26 |